The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
Open accessAbstract
Never make forecasts. Especially about the future. —Samuel Goldwyn The use of biomarkers to augment traditional cardiovascular risk prediction has attracted considerable attention in the past decade. This interest has been fueled by the realization that traditional risk factors do not identify everyone who will eventually develop cardiovascular disease.1 This has been accompanied by the emergence of potential screening tests such as high-sensitivity C-reactive protein (CRP), single-nucleotide polymorphism arrays, and coronary calcium scanning. Nonetheless, whether these biomarkers are ready for routine clinical use, to be measured alongside existing tests such as cholesterol, is controversial. Recently, the US Preventive Services Task Force concluded that “current evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors.”2 This conclusion underscores gaps in the current literature, as well as the inherent challenge of predicting the occurrence of future cardiovascular events in generally healthy adults. However, the use of newer screening tests for cardiovascular risk assessment has been endorsed in some quarters. For instance, the state of Texas passed legislation in 2009 mandating the coverage of screening coronary calcium scans in older adults. Furthermore, the Food and Drug Administration recently expanded the labeling of a statin drug, rosuvastatin, to include older individuals with elevated CRP levels in addition to conventional risk factors. The present article reviews the case for and against the use of newer biomarkers for cardiovascular risk prediction. There are literally hundreds of circulating, genetic, and imaging biomarkers that have been proposed or evaluated in the cardiovascular literature. Several comprehensive reviews exist on the topic.3,4 Rather than attempting to provide a systematic overview, this article focuses on a few of the most illustrative biomarkers. Particular emphasis will be given to placing these biomarkers in a pathophysiological context (what stage of disease …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 1×
“For references, see text and prior reviews on this topic.(10,17,25) The list contains the metrics used most commonly in the biomarker literature.”
MethodPearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
Vlachopoulos, C., Aznaouridis, K., & Stefanadis, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.061 · Cited by 4,165
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Targeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study
Mitchell, G. F., Hwang, S.-J., Vasan, R. S., Larson, M. G., Pencina, M. J., Hamburg, N. M., Vita, J. A., Levy, D., & Benjamin, E. J. (2010) · Circulation · doi:10.1161/circulationaha.109.886655 · Cited by 2,225
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,112
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Genomewide Association Analysis of Coronary Artery Disease
Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H.-E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072366 · Cited by 2,044
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,946
Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study
Mattace-Raso, F. U. S., van der Cammen, T. J. M., Hofman, A., van Popele, N. M., Bos, M. L., Schalekamp, M. A. D. H., Asmar, R., Reneman, R. S., Hoeks, A. P. G., Breteler, M. M. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.555235 · Cited by 1,914
KANNEL, W. B., DAWBER, T. R., KAGAN, A., REVOTSKIE, N., & STOKES, J. (1961) · Annals of Internal Medicine · doi:10.7326/0003-4819-55-1-33 · Cited by 1,837
Greenland, P. (2004) · JAMA · doi:10.1001/jama.291.2.210 · Cited by 1,829
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
Ransohoff, D. F., & Feinstein, A. R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810262991705 · Cited by 1,734
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
A Common Allele on Chromosome 9 Associated with Coronary Heart Disease
McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., Hinds, D. A., Pennacchio, L. A., Tybjaerg-Hansen, A., Folsom, A. R., et al. (2007) · Science · doi:10.1126/science.1142447 · Cited by 1,587
A strategy to reduce cardiovascular disease by more than 80%
Wald, N. J., & Law, M. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1419 · Cited by 1,568
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,527
Self-citationPrevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Khot, U. N. (2003) · JAMA · doi:10.1001/jama.290.7.898 · Cited by 1,494
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
Self-citationBiomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Hlatky, M. A., Greenland, P., Arnett, D. K., Ballantyne, C. M., Criqui, M. H., Elkind, M. S. V., Go, A. S., Harrell, F. E., Hong, Y., Howard, B. V., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192278 · Cited by 1,139
Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction
Polonsky, T. S. (2010) · JAMA · doi:10.1001/jama.2010.461 · Cited by 1,119
Myocardial Infarction Genetics Consortium (2009) · Nature Genetics · doi:10.1038/ng.327 · Cited by 1,088
Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events
Greenland, P. (2003) · JAMA · doi:10.1001/jama.290.7.891 · Cited by 1,050
A, P. T., A, M. G., & W, A. R. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00016 · Cited by 1,024
Arad, Y., Goodman, K. J., Roth, M., Newstein, D., & Guerci, A. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.088 · Cited by 984
Greenland, P., Bonow, R. O., Brundage, B. H., Budoff, M. J., Eisenberg, M. J., Grundy, S. M., Lauer, M. S., Post, W. S., Raggi, P., Redberg, R. F., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.001 · Cited by 962
Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938
Greenland (2000) · doi:10.1161/01.cir.101.1.e16 · Cited by 924
Yeboah, J., Crouse, J. R., Hsu, F.-C., Burke, G. L., & Herrington, D. M. (2007) · Circulation · doi:10.1161/circulationaha.106.678276 · Cited by 891
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 889
Yeboah, J., Folsom, A. R., Burke, G. L., Johnson, C., Polak, J. F., Post, W., Lima, J. A., Crouse, J. R., & Herrington, D. M. (2009) · Circulation · doi:10.1161/circulationaha.109.864801 · Cited by 888
Genetically elevated C-reactive protein and ischemic vascular disease
Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839
Gokce, N., Keaney, J. F., Hunter, L. M., Watkins, M. T., Menzoian, J. O., & Vita, J. A. (2002) · Circulation · doi:10.1161/01.cir.0000012543.55874.47 · Cited by 783
Gokce, N., Keaney, J. F., Hunter, L. M., Watkins, M. T., Nedeljkovic, Z. S., Menzoian, J. O., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00333-4 · Cited by 776
Erbel, R., Möhlenkamp, S., Moebus, S., Schmermund, A., Lehmann, N., Stang, A., Dragano, N., Grönemeyer, D., Seibel, R., Kälsch, H., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.030 · Cited by 771
Cardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions
Lloyd-Jones, D. M. (2010) · Circulation · doi:10.1161/circulationaha.109.849166 · Cited by 705
Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
Kathiresan, S., Melander, O., Anevski, D., Guiducci, C., Burtt, N. P., Roos, C., Hirschhorn, J. N., Berglund, G., Hedblad, B., Groop, L., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706728 · Cited by 696
Folsom, A. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.12.1333 · Cited by 683
Danesh, J., Kaptoge, S., Mann, A. G., Sarwar, N., Wood, A., Angleman, S. B., Wensley, F., Higgins, J. P. T., Lennon, L., Eiriksdottir, G., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050078 · Cited by 676
Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness
Taylor, A. J., Villines, T. C., Stanek, E. J., Devine, P. J., Griffen, L., Miller, M., Weissman, N. J., & Turco, M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907569 · Cited by 644
Taylor, A. J., Bindeman, J., Feuerstein, I., Cao, F., Brazaitis, M., & O’Malley, P. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.049 · Cited by 634
Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women
Modena, M. G., Bonetti, L., Coppi, F., Bursi, F., & Rossi, R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01976-9 · Cited by 575
Pletcher, M. J., Tice, J. A., Pignone, M., & Browner, W. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1285 · Cited by 567
Benchmarks for the Assessment of Novel Cardiovascular Biomarkers
Morrow, D. A., & de Lemos, J. A. (2007) · Circulation · doi:10.1161/circulationaha.106.683110 · Cited by 561
Buckley, D. I., Fu, R., Freeman, M., Rogers, K., & Helfand, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00009 · Cited by 559
Greenland, P., Smith Jr, S. C., & Grundy, S. M. (2001) · Circulation · doi:10.1161/hc4201.097189 · Cited by 553
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander, O. (2009) · JAMA · doi:10.1001/jama.2009.943 · Cited by 551
Coronary Calcification Improves Cardiovascular Risk Prediction in the Elderly
Vliegenthart, R., Oudkerk, M., Hofman, A., Oei, H.-H. S., van Dijck, W., van Rooij, F. J. A., & Witteman, J. C. M. (2005) · Circulation · doi:10.1161/circulationaha.104.488916 · Cited by 540
A Common Allele on Chromosome 9 Associated With Coronary Heart Disease
McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., Hinds, D. A., Pennacchio, L. A., Tybjaerg-Hansen, A., Folsom, A. R., et al. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000279314.45442.bb · Cited by 524
The effect of including C-reactive protein in cardiovascular risk prediction models for women
Cook, N. R., Buring, J. E., & Ridker, P. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00128 · Cited by 504
Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment Trials
Sargent, D. J., Conley, B. A., Allegra, C., & Collette, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.112 · Cited by 499
New susceptibility locus for coronary artery disease on chromosome 3q22.3
Italian Atherosclerosis, T., Erdmann, J., Myocardial Infarction Genetics Consortium, Wellcome Trust Case Control Consortium, Cardiogenics Consortium, Großhennig, A., Braund, P. S., König, I. R., Hengstenberg, C., Hall, A. S., et al. (2009) · Nature Genetics · doi:10.1038/ng.307 · Cited by 484
Brevetti, G., Silvestro, A., Schiano, V., & Chiariello, M. (2003) · Circulation · doi:10.1161/01.cir.0000095273.92468.d9 · Cited by 482
Wellcome Trust Case Control Consortium, Trégouët, D.-A., Cardiogenics Consortium, König, I. R., Erdmann, J., Munteanu, A., Braund, P. S., Hall, A. S., Großhennig, A., Linsel-Nitschke, P., et al. (2009) · Nature Genetics · doi:10.1038/ng.314 · Cited by 475
The Limitations of Risk Factors as Prognostic Tools
Ware, J. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068249 · Cited by 466
Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin Therapy
Shishehbor, M. H., Aviles, R. J., Brennan, M.-L., Fu, X., Goormastic, M., Pearce, G. L., Gokce, N., Keaney, J. F., Penn, M. S., Sprecher, D. L., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1675 · Cited by 464
Cook, N. R., & Ridker, P. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00007 · Cited by 458
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Rajpathak, S. N., Kumbhani, D. J., Crandall, J., Barzilai, N., Alderman, M., & Ridker, P. M. (2009) · Diabetes Care · doi:10.2337/dc09-0738 · Cited by 439
Meisinger, C., Baumert, J., Khuseyinova, N., Loewel, H., & Koenig, W. (2005) · Circulation · doi:10.1161/circulationaha.104.529297 · Cited by 434
Helfand, M., Buckley, D. I., Freeman, M., Fu, R., Rogers, K., Fleming, C., & Humphrey, L. L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00010 · Cited by 382
Bots, M. L., Evans, G. W., Riley, W. A., & Grobbee, D. E. (2003) · Stroke · doi:10.1161/01.str.0000102044.27905.b5 · Cited by 379
Di Angelantonio, E., Chowdhury, R., Sarwar, N., Ray, K. K., Gobin, R., Saleheen, D., Thompson, A., Gudnason, V., Sattar, N., & Danesh, J. (2009) · Circulation · doi:10.1161/circulationaha.109.884866 · Cited by 378
Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the Elderly
Elias-Smale, S. E., Proença, R. V., Koller, M. T., Kavousi, M., van Rooij, F. J. A., Hunink, M. G., Steyerberg, E. W., Hofman, A., Oudkerk, M., & Witteman, J. C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.029 · Cited by 369
Blankenberg, S., Zeller, T., Saarela, O., Havulinna, A. S., Kee, F., Tunstall-Pedoe, H., Kuulasmaa, K., Yarnell, J., Schnabel, R. B., Wild, P. S., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.901413 · Cited by 367
The search for new cardiovascular biomarkers
Gerszten, R. E., & Wang, T. J. (2008) · Nature · doi:10.1038/nature06802 · Cited by 358
Self-citationFolsom, A. R., Chambless, L. E., Ballantyne, C. M., Coresh, J., Heiss, G., Wu, K. K., Boerwinkle, E., Mosley, T. H., Sorlie, P., Diao, G., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1368 · Cited by 358
Cao, J. J., Arnold, A. M., Manolio, T. A., Polak, J. F., Psaty, B. M., Hirsch, C. H., Kuller, L. H., & Cushman, M. (2007) · Circulation · doi:10.1161/circulationaha.106.645606 · Cited by 347
Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis
Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P., Rumley, A., & Lowe, G. D. O. (2001) · Circulation · doi:10.1161/01.cir.103.19.2323 · Cited by 344
Spectrum Bias or Spectrum Effect? Subgroup Variation in Diagnostic Test Evaluation
Mulherin, S. A., & Miller, W. C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00011 · Cited by 327
Chan, S. Y., Mancini, G. B. J., Kuramoto, L., Schulzer, M., Frohlich, J., & Ignaszewski, A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00927-6 · Cited by 326
Koenig, W., Khuseyinova, N., Löwel, H., Trischler, G., & Meisinger, C. (2004) · Circulation · doi:10.1161/01.cir.0000143377.53389.c8 · Cited by 311
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Wilson, P. W. F., Pencina, M., Jacques, P., Selhub, J., D'Agostino, R., & O'Donnell, C. J. (2008) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.831198 · Cited by 299
The Value of Carotid Intima-Media Thickness for Predicting Cardiovascular Risk
Simon, A., Megnien, J.-L., & Chironi, G. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.196980 · Cited by 286
Bibbins-Domingo, K., Gupta, R., Na, B., Wu, A. H. B., Schiller, N. B., & Whooley, M. A. (2007) · JAMA · doi:10.1001/jama.297.2.169 · Cited by 276
Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease
Lloyd-Jones, D. M., Liu, K., Tian, L., & Greenland, P. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00129 · Cited by 274
NT-ProBNP: The Mechanism Behind the Marker
Hall, C. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.04.019 · Cited by 273
Huang, A. L., Silver, A. E., Shvenke, E., Schopfer, D. W., Jahangir, E., Titas, M. A., Shpilman, A., Menzoian, J. O., Watkins, M. T., Raffetto, J. D., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147322 · Cited by 262
Paynter, N. P., Chasman, D. I., Buring, J. E., Shiffman, D., Cook, N. R., & Ridker, P. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00003 · Cited by 262
Blankenberg, S., McQueen, M. J., Smieja, M., Pogue, J., Balion, C., Lonn, E., Rupprecht, H. J., Bickel, C., Tiret, L., Cambien, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.590927 · Cited by 256
Lipoprotein-Associated Phospholipase A
Krumholz, H. (2001) · Journal watch · doi:10.1056/jc200101050000008 · Cited by 254
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice
Hirschfield, G. M., Gallimore, J. R., Kahan, M. C., Hutchinson, W. L., Sabin, C. A., Benson, G. M., Dhillon, A. P., Tennent, G. A., & Pepys, M. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503202102 · Cited by 192
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00008 · Cited by 180
Novel Risk Markers and Clinical Practice
Manolio, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038136 · Cited by 174
The Use of Genomics in Clinical Trial Design
Simon, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4531 · Cited by 170
Ridker, P. M., MacFadyen, J., Libby, P., & Glynn, R. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.018 · Cited by 160
Persson, M., Hedblad, B., Nelson, J. J., & Berglund, G. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142679 · Cited by 152
Elements of Danger — The Case of Medical Imaging
Lauer, M. S. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0904735 · Cited by 137
Olsen, M. H., Hansen, T. W., Christensen, M. K., Gustafsson, F., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-Pedersen, C. T., & Hildebrandt, P. R. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl448 · Cited by 136
Trion, A., de Maat, M. P. M., Jukema, J. W., van der Laarse, A., Maas, M., Offerman, E. H., Havekes, L. M., Szalai, A. J., Princen, H. M. G., & EMEIS, J. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000171992.36710.1e · Cited by 116
Kovacs, A., Tornvall, P., Nilsson, R., Tegner, J. N., Hamsten, A., & Björkegren, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706027104 · Cited by 111
Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic Rabbits
Koike, T., Kitajima, S., Yu, Y., Nishijima, K., Zhang, J., Ozaki, Y., Morimoto, M., Watanabe, T., Bhakdi, S., Asada, Y., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.872796 · Cited by 104
Tennent, G. A., Hutchinson, W. L., Kahan, M., Hirschfield, G. M., Gallimore, J. R., Lewin, J. F., Sabin, C. A., Dhillon, A. P., & Pepys, M. B. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.010 · Cited by 100
Randomized Phase III Clinical Trial Designs for Targeted Agents
Hoering, A., LeBlanc, M., & Crowley, J. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0288 · Cited by 89
Patterson, C., Smith, A. E., YARNELL, J. W. G., Rumley, A., Ben‐Shlomo, Y., & Lowe, G. D. O. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.030 · Cited by 88
What Makes a Good Predictor?: The Evidence Applied to Coronary Artery Calcium Score
Ioannidis, J. P. A., & Tzoulaki, I. (2010) · JAMA · doi:10.1001/jama.2010.503 · Cited by 81
Clinical and Research Applications of Carotid Intima-Media Thickness
Sharma, K., Blaha, M. J., Blumenthal, R. S., & Musunuru, K. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.020 · Cited by 75
Expanding the Orbit of Primary Prevention — Moving beyond JUPITER
Hlatky, M. A. (2008) · New England Journal of Medicine · doi:10.1056/nejme0808320 · Cited by 69
By Jove! What Is a Clinician to Make of JUPITER?
Kaul, S., Morrissey, R. P., & Diamond, G. A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.189 · Cited by 68
C-Reactive Protein and Coronary Disease: Is There a Causal Link?
Danesh, J., & Pepys, M. B. (2009) · Circulation · doi:10.1161/circulationaha.109.907212 · Cited by 61
Noninvasive Screening for Coronary Artery Disease With Computed Tomography Is Useful
Clouse, M. E. (2006) · Circulation · doi:10.1161/circulationaha.104.478354 · Cited by 54
Biomarkers for cardiovascular disease: challenges and future directions
May, A., & Wang, T. J. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.04.003 · Cited by 47
Self-citationBiomarkers for Prediction of Cardiovascular Events
Musunuru, K., & Blumenthal, R. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070079 · Cited by 41
Multiple Biomarkers for Predicting Cardiovascular Events
Wang, T. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.019 · Cited by 39
Self-citationGenetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Elliott, P. (2009) · JAMA · doi:10.1001/jama.2009.954 · Cited by 35
Can the polypill save the world from heart disease?
Cannon, C. P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60652-8 · Cited by 35
CASLAKE, M. J., Packard, C. J., Robertson, M., Cooney, J., Nelson, J. J., Ford, I., Gaw, A., Jukema, J. W., Macfarlane, P. W., Stott, D. J., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.041 · Cited by 26
de Lemos, J. A., & Rohatgi, A. K. (2010) · Circulation · doi:10.1161/circulationaha.110.953463 · Cited by 10
Cited by
DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays
Singh, A., Shannon, C. P., Gautier, B., Rohart, F., Vacher, M., Tebbutt, S. J., & Lê Cao, K.-A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty1054 · Cited by 1,072
Thijssen, D. H. J., Bruno, R. M., van Mil, A. C. C. M., Holder, S. M., Faita, F., Greyling, A., Zock, P. L., Taddei, S., Deanfield, J. E., Luscher, T., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz350 · Cited by 995
Soininen, P., Kangas, A. J., Würtz, P., Suna, T., & Ala-Korpela, M. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000216 · Cited by 900
Biological markers of oxidative stress: Applications to cardiovascular research and practice
Ho, E., Karimi Galougahi, K., Liu, C.-C., Bhindi, R., & Figtree, G. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.006 · Cited by 811
Mega, J. L., Stitziel, N. O., Smith, J. G., Chasman, D. I., Caulfield, M. J., Devlin, J. J., Nordio, F., Hyde, C. L., Cannon, C. P., Sacks, F. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61730-x · Cited by 704
Metadata
- Authors
- Wang, T. J.
- Venue
- Circulation
- Published
- 2011-02-08
- Volume
- 123
- Issue
- 5
- Pages
- 551-565
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2048530377
- Cited by
- 294
- References
- 128
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.